Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-31
2005-05-31
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S266200, C514S365000, C514S367000, C514S406000
Reexamination Certificate
active
06900219
ABSTRACT:
The present invention provides compounds that elevate cellular expression of the ABCA-1 gene, promoting cholesterol efflux from cells and increasing HDL levels in the plasma of a mammal, in particular humans. The compounds are useful for treating coronary artery disease.
REFERENCES:
patent: 6548548 (2003-04-01), Campbell et al.
patent: 2002/0082257 (2002-06-01), Ibrahim et al.
patent: 2002/0128266 (2002-09-01), Campbell et al.
patent: 2003/0069234 (2003-04-01), Medina et al.
patent: WO 01/16114 (2001-03-01), None
patent: WO 02/083143 (2002-10-01), None
patent: WO 01/81346 (2002-11-01), None
Campbell Michael
Ibrahim Prabha
Jiang Robert
Koltun Dmitry
Morrison Christopher
CV Therapeutics Inc.
Hartrum J. Elin
Henley III Raymond J.
Lewis Brian
LandOfFree
ABCA-1 elevating compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ABCA-1 elevating compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ABCA-1 elevating compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3368597